Trials / Not Yet Recruiting
Not Yet RecruitingNCT06938282
An Exploratory Clinical Study of HRS-4642 in Combination With Immunotherapy and Chemotherapy for Pancreatic Cancer
- Status
- Not Yet Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Shanghai Zhongshan Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the safety and efficacy of HRS-4642 in combination with immunotherapy and chemotherapy in borderline resectable, locally advanced/metastatic pancreatic cancer
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS-4642 | HRS-4642 in Combination with Immunotherapy and Chemotherapy |
Timeline
- Start date
- 2025-05-01
- Primary completion
- 2027-04-30
- Completion
- 2029-04-30
- First posted
- 2025-04-22
- Last updated
- 2025-04-25
Source: ClinicalTrials.gov record NCT06938282. Inclusion in this directory is not an endorsement.